Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGLIF.L Regulatory News (GLIF)

  • There is currently no data for GLIF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of placing

25 Jun 2007 18:19

T2 Income Fund Limited25 June 2007 RNS Number:T2 Income Fund Limited25 June 2007 Not for release, publication or distribution in, or into, the United States,Australia, Canada or Japan 25 June 2007 T2 Income Fund Limited RESULT OF PLACING OF NEW ORDINARY SHARES T2 Income Fund Limited (the "Company") announces that, further to theannouncement on 22 June 2007 (the "Announcement"), a total of 5 million newordinary shares in the Company (the "Placing Shares") have been placed byJPMorgan Cazenove at a price of 101.75 pence per Placing Share, raising grossproceeds of approximately £5,087,500 (the "Placing"). The Placing Shares will be issued credited as fully paid and will rank paripassu with the Company's existing ordinary shares, including the right toreceive all dividends and other distributions declared, made or paid on or inrespect of such shares after the date of issue of the Placing Shares.Application has been made for admission of such Shares to trading on the AIMMarket of the London Stock Exchange plc. Grant Thornton Corporate Finance actsas Nominated Adviser to the Company. Dealings in these Placing Shares areexpected to commence on 28 June 2007. Following admission of these PlacingShares there will be 43,000,000 ordinary shares in issue. Jonathan Cohen, chief executive officer of the Investment Manager, and SaulRosenthal, president of the Investment Manager and Non-Independent Director ofthe Company both participated in the placing subscribing for 125,000 PlacingShares each, taking their existing holdings in the Company to 129,000 ordinaryshares (0.3% of the total voting rights of the Company) and 125,000 ordinaryshares (0.3% of the total voting rights of the Company) respectively. Mr Cohenand Mr Rosenthal additionally each hold an interest through an option previouslygranted to the Investment Manager by the Company of 1,194,444 ordinary shares(2.5% of the total voting rights of the Company, on the basis of the issuedshare capital of the Company following exercise of the option). The shareholdings of existing substantial shareholders may change following theissue of the Placing Shares. The Company will issue a notification at a laterdate if it becomes aware of any relevant changes in such shareholdings that arerequired to be notified in accordance with Rule 17 of the AIM Rules. Enquiries: T2 Income Fund Limited:T2 Income Fund Limited:Patrick Conroy, +1 203 983 5282 Grant Thornton Corporate Finance (Nominated Adviser):Philip Secrett / Fiona Kindness, +44 207 383 5100 JPMorgan Cazenove:Angus Gordon Lennox, +44 207 588 2828 Defined terms used in this announcement have, unless the context otherwiserequires, the same meaning given to them in the Announcement. This announcement has been issued by and is the sole responsibility of T2 IncomeFund Limited. JPMorgan Cazenove is acting for the Company and no-one else in relation to thePlacing and will not be responsible to any person other than the Company forproviding the protections afforded to clients or for providing advice inrelation to the Placing or in relation to the contents of this announcement orany other transaction, arrangement or matter referred to herein. This announcement is for information purposes only and does not constitute anoffer to issue or sell, or the solicitation of an offer to acquire or buy, anysecurities to any person in any jurisdiction. In particular, this announcementdoes not constitute an offer to issue or sell, or the solicitation of an offerto acquire, buy or subscribe for, any securities in the United States, Canada,Australia and Japan. The Placing Shares have not been, nor will they be, registered under theSecurities Act or with any securities regulatory authority of any State or otherjurisdiction of the United States, and accordingly may not be offered, sold ortransferred within the United States except pursuant to an exemption from, or ina transaction not subject to, registration under the Securities Act. No publicoffering of the Placing shares will be made in the United States. The PlacingShares are being offered and sold outside the United States to persons who arenot U.S. persons as defined in and in accordance with Regulation S under theSecurities Act ("U.S. Persons"). The Company has not been and will not beregistered under the Investment Company Act and investors will not be entitledto the benefits of such registration. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
18th Sep 20137:00 amRNSAdditional Listing
2nd Sep 20137:00 amRNSInvestment in crowd-funding platform
16th Aug 20134:15 pmRNSHolding(s) in Company
25th Jul 20137:58 amRNSNAV and Trading Update
25th Jul 20137:58 amRNSDividend Declaration
16th Jul 20137:00 amRNSInvestment
17th Jun 20137:00 amRNSDirector/PDMR Shareholding
14th Jun 20137:00 amRNSAdditional Listing
10th Jun 201311:00 amRNSShare Dealing
6th Jun 20134:00 pmRNSDirector/PDMR Shareholding
24th May 20135:00 pmRNSDirector/PDMR Shareholding
22nd May 20138:00 amRNSDirector/PDMR Shareholding
17th May 20139:00 amRNSDirector/PDMR Shareholding
15th May 20138:20 amRNSDirector/PDMR Shareholding
14th May 20134:30 pmRNSDirector/PDMR Shareholding
13th May 20138:00 amRNSHolding(s) in Company
30th Apr 20134:00 pmRNSResult of AGM
25th Apr 20138:30 amRNSHolding(s) in Company
23rd Apr 20134:45 pmRNSDirector/PDMR Shareholding
22nd Apr 20133:15 pmRNSHolding(s) in Company
18th Apr 20138:15 amRNSDividend Declaration
18th Apr 20138:15 amRNSNAV Update and CLO Test Result
9th Apr 20135:30 pmRNSAnnual Report
3rd Apr 20137:00 amRNSFull Year Results 2012
28th Mar 20137:02 amRNSNotice of Preliminary Results
23rd Jan 20137:01 amRNSPlacing
23rd Jan 20137:00 amRNSNAV Update, dividend payment and CLO Test Results
18th Jan 20132:49 pmRNSDirector/PDMR Shareholding
19th Nov 20122:30 pmRNSHolding(s) in Company
14th Nov 201212:00 pmRNSHolding(s) in Company
13th Nov 20128:00 amRNSHolding(s) in Company
12th Nov 201212:30 pmRNSDirector/PDMR Shareholding
8th Nov 201212:45 pmRNSConfirmation of Final Consideration Payable
7th Nov 20127:00 amRNSAcquisition
29th Oct 20127:00 amRNSAnnouncement of Dividend
19th Oct 20127:00 amRNSNAV Update and Quarterly CLO Test Results
20th Sep 20127:00 amRNSHalf Year Results 2012 Replacement
18th Sep 20126:27 pmRNSDirector/PDMR Shareholding
14th Sep 20127:00 amRNSHalf Year Results 2012
19th Jul 20129:00 amRNSTrading Statement
17th Jul 20123:51 pmRNSHolding(s) in Company
30th Apr 20125:00 pmRNSResult of AGM
20th Apr 20129:30 amRNSQuarterly CLO Test Results
19th Apr 20125:00 pmRNSNAV Update and dividend
5th Apr 20127:00 amRNSAnnual Financial Report
30th Mar 20122:46 pmRNSDealing by Investment Manager
26th Mar 20127:00 amRNSFull Year Results 2011
13th Mar 20127:00 amRNSNotice of Results
12th Mar 20127:00 amRNSChange of Adviser
19th Jan 20124:50 pmRNSNAV Update and Dividend Payment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.